Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
87.87
+2.27 (2.65%)
Jun 1, 2026, 1:45 PM EDT - Market open
Abbott Laboratories Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 153,053 | 217,579 | 195,872 | 190,870 | 190,793 | 248,277 | |
Market Cap Growth | -31.53% | 11.08% | 2.62% | 0.04% | -23.15% | 28.02% |
Enterprise Value | 177,578 | 219,177 | 200,767 | 197,414 | 195,364 | 255,546 |
Last Close Price | 87.87 | 125.29 | 113.11 | 110.07 | 109.79 | 140.74 |
PE Ratio | 23.98 | 33.68 | 14.81 | 33.76 | 28.08 | 35.72 |
Forward PE | 15.28 | 22.63 | 22.39 | 24.22 | 26.64 | 30.05 |
PEG Ratio | 1.61 | 2.35 | 2.61 | 2.85 | 5.16 | 2.38 |
PS Ratio | 3.34 | 4.91 | 4.67 | 4.76 | 4.37 | 5.76 |
PB Ratio | 2.86 | 4.17 | 4.11 | 4.94 | 5.20 | 6.93 |
P/TBV Ratio | 2.95 | 4.20 | 4.15 | 4.99 | 5.28 | 7.03 |
P/FCF Ratio | 20.43 | 29.42 | 30.84 | 37.73 | 24.45 | 28.71 |
P/OCF Ratio | 15.93 | 22.75 | 22.89 | 26.29 | 19.91 | 23.57 |
EV/Sales Ratio | 3.93 | 4.94 | 4.79 | 4.92 | 4.48 | 5.93 |
EV/EBITDA Ratio | 15.12 | 19.62 | 19.99 | 20.31 | 16.80 | 21.36 |
EV/EBIT Ratio | 20.69 | 27.22 | 29.42 | 30.47 | 23.36 | 30.33 |
EV/FCF Ratio | 24.07 | 29.64 | 31.61 | 39.02 | 25.03 | 29.55 |
Debt / Equity Ratio | 0.56 | 0.19 | 0.26 | 0.35 | 0.39 | 0.48 |
Debt / EBITDA Ratio | 3.13 | 1.16 | 1.41 | 1.51 | 1.44 | 1.51 |
Debt / FCF Ratio | 4.62 | 1.75 | 2.22 | 2.90 | 2.15 | 2.09 |
Net Debt / Equity Ratio | 0.51 | 0.08 | 0.13 | 0.19 | 0.18 | 0.22 |
Net Debt / EBITDA Ratio | 2.46 | 0.36 | 0.61 | 0.76 | 0.57 | 0.65 |
Net Debt / FCF Ratio | 3.63 | 0.54 | 0.97 | 1.46 | 0.85 | 0.90 |
Asset Turnover | 0.46 | 0.53 | 0.54 | 0.54 | 0.58 | 0.58 |
Inventory Turnover | 2.93 | 3.05 | 2.93 | 2.82 | 3.38 | 3.65 |
Quick Ratio | 1.01 | 1.18 | 1.23 | 1.16 | 1.23 | 1.46 |
Current Ratio | 1.39 | 1.58 | 1.67 | 1.64 | 1.63 | 1.85 |
Return on Equity (ROE) | 11.90% | 12.96% | 30.91% | 15.11% | 19.01% | 20.49% |
Return on Assets (ROA) | 6.03% | 7.38% | 16.87% | 7.54% | 9.33% | 9.82% |
Return on Invested Capital (ROIC) | 7.58% | 9.67% | 22.29% | 10.41% | 13.17% | 13.36% |
Return on Capital Employed (ROCE) | 9.50% | 11.72% | 10.78% | 10.95% | 13.82% | 13.73% |
Earnings Yield | 4.15% | 2.97% | 6.75% | 2.96% | 3.56% | 2.80% |
FCF Yield | 4.89% | 3.40% | 3.24% | 2.65% | 4.09% | 3.48% |
Dividend Yield | 2.87% | 1.89% | 1.95% | 1.86% | 1.72% | 1.28% |
Payout Ratio | 68.35% | 63.09% | 28.62% | 62.14% | 47.73% | 45.28% |
Buyback Yield / Dilution | -0.03% | 0.00% | 0.06% | 0.85% | 1.40% | -0.17% |
Total Shareholder Return | 2.84% | 1.89% | 2.01% | 2.71% | 3.12% | 1.11% |